Crossmark

Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials

Published Online: 2024-05-20

Published Print: 2024-10

Authors

Marinheiro, Gabriel https://orcid.org/0009-0001-8040-6515
Dantas, Julyana Medeiros

Mutarelli, Antonio

Menegaz de Almeida, Artur

Monteiro, Gabriel de Almeida

Zerlotto, Djinane Spinosa

Telles, João Paulo Mota
License Information

Text and Data Mining valid from 2024-05-20

Version of Record valid from 2024-05-20
More Information

Article History

Received: 21 March 2024

Accepted: 29 April 2024

First Online: 20 May 2024

Declarations

:

: This is a systematic review and meta-analysis. No ethical approval was required as no new patient data was collected.

: The authors have no conflict of interest to declare.

Document is current